Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter

فلترة النتائج

Subject : 03 medical and health sciences Subject : biomarkers, tumor Subject : prostatic neoplasms Subject : surgery فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma.

  • Authors : Fang S; Department of Stomatology, Huashan hospital, Fudan university, Shanghai, 200040, China.; Zhou Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality

  • Source: BMC gastroenterology [BMC Gastroenterol] 2024 Jun 24; Vol. 24 (1), pp. 210. Date of Electronic Publication: 2024 Jun 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Development and validation of a biomarker index for HCC treatment response.

  • Authors : Liang J; Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Li PY

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/blood ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy

  • Source: Hepatology communications [Hepatol Commun] 2024 Jun 19; Vol. 8 (7). Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024).Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma.

  • Authors : Zhang S; Centre for Medical Research, Ningbo No. 2 Hospital, Ningbo, 315010, China.; Tuo P

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/blood ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/virology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnosis

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jun 18; Vol. 150 (6), pp. 310. Date of Electronic Publication: 2024 Jun 18.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A novel algorithm to differentiate between primary lung tumors and distant liver metastasis in lung cancers using an exosome based multi gene biomarker panel.

  • Authors : Shah KA; Division of Biological and Life Science, Ahmedabad University, Ahmedabad, Gujarat, India.; Rawal RM

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/secondary ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/diagnosis

  • Source: Scientific reports [Sci Rep] 2024 Jun 14; Vol. 14 (1), pp. 13769. Date of Electronic Publication: 2024 Jun 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma.

  • Authors : Liu Z; Department of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.; Yang L

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy

  • Source: Frontiers in immunology [Front Immunol] 2024 Jun 12; Vol. 15, pp. 1371829. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma.

  • Authors : Chen C; Department of General Surgery, Xishan People's Hospital of Wuxi City, Wuxi, China.; Chen Z

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality

  • Source: Frontiers in immunology [Front Immunol] 2024 Jun 11; Vol. 15, pp. 1424752. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma.

  • Authors : He L; Department of Organ Transplantation, The Third Medical Centre of Chinese PLA General Hospital, Beijing 100039, China.; School of Clinical Medicine, Shandong Second Medical University, Weifang 261053, Shandong Province, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: World journal of gastroenterology [World J Gastroenterol] 2024 Jun 07; Vol. 30 (21), pp. 2763-2776.Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.

  • Authors : Yang J; Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.; Fan LY

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: International journal of medical sciences [Int J Med Sci] 2024 Jun 03; Vol. 21 (8), pp. 1559-1574. Date of Electronic Publication: 2024 Jun 03 (Print Publication: 2024).Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101213954 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT.

  • Authors : Le Z; The First Affiliated Hospital of Jinan University, Guangzhou, China.; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Subjects: Epithelial-Mesenchymal Transition* ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/secondary ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics

  • Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Jun; Vol. 7 (6), pp. e2079.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lysosome-Related Genes and RNF19B as Prognostic Markers for Survival and Immunotherapy Efficacy in Hepatocellular Carcinoma.

  • Authors : Li J; Department of Pathology, Medical School of Nantong University & Department of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, China.; Wang H

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology

  • Source: Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2024 Jun 01; Vol. 15 (6), pp. e1. Date of Electronic Publication: 2024 Jun 01.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101532142 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×